Cracking the code: Deciphering the role of the tumor microenvironment in osteosarcoma metastasis

Int Immunopharmacol. 2023 Aug:121:110422. doi: 10.1016/j.intimp.2023.110422. Epub 2023 Jun 9.

Abstract

Osteosarcoma (OS) is the most common malignant bone tumor in children and adolescents. It is characterized by a rapid progression, poor prognosis, and early pulmonary metastasis. Over the past 30 years, approximately 85% of patients with osteosarcoma have experienced metastasis. The five-year survival of patients with lung metastasis during the early stages of treatment is less than 20%. The tumor microenvironment (TME) not only provides conditions for tumor cell growth but also releases a variety of substances that can promote the metastasis of tumor cells to other tissues and organs. Currently, there is limited research on the role of the TME in osteosarcoma metastasis. Therefore, to explore methods for regulating osteosarcoma metastasis, further investigations must be conducted from the perspective of the TME. This will help to identify new potential biomarkers for predicting osteosarcoma metastasis and assist in the discovery of new drugs that target regulatory mechanisms for clinical diagnosis and treatment. This paper reviews the research progress on the mechanism of osteosarcoma metastasis based on TME theory, which will provide guidance for the clinical treatment of osteosarcoma.

Keywords: Metastasis; Osteosarcoma; Tumor associated macrophage; Tumor immunotherapy; Tumor microenvironment.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Bone Neoplasms* / drug therapy
  • Child
  • Humans
  • Lung Neoplasms* / drug therapy
  • Osteosarcoma* / drug therapy
  • Prognosis
  • Tumor Microenvironment